1. Home
  2. HWBK vs SLGL Comparison

HWBK vs SLGL Comparison

Compare HWBK & SLGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

HWBK

Hawthorn Bancshares Inc.

HOLD

Current Price

$32.62

Market Cap

228.8M

Sector

Finance

ML Signal

HOLD

Logo Sol-Gel Technologies Ltd.

SLGL

Sol-Gel Technologies Ltd.

HOLD

Current Price

$77.09

Market Cap

247.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HWBK
SLGL
Founded
1865
1997
Country
United States
Israel
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
228.8M
247.1M
IPO Year
1996
2016

Fundamental Metrics

Financial Performance
Metric
HWBK
SLGL
Price
$32.62
$77.09
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$110.00
AVG Volume (30 Days)
3.1K
10.5K
Earning Date
04-29-2026
04-28-2026
Dividend Yield
2.58%
N/A
EPS Growth
31.42
N/A
EPS
3.43
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$122.71
Revenue Next Year
N/A
N/A
P/E Ratio
$9.50
N/A
Revenue Growth
N/A
N/A
52 Week Low
$25.50
$0.40
52 Week High
$36.25
$97.97

Technical Indicators

Market Signals
Indicator
HWBK
SLGL
Relative Strength Index (RSI) 41.87 48.42
Support Level $32.33 $71.01
Resistance Level $33.71 $96.99
Average True Range (ATR) 0.83 10.76
MACD -0.11 -2.27
Stochastic Oscillator 6.64 25.37

Price Performance

Historical Comparison
HWBK
SLGL

About HWBK Hawthorn Bancshares Inc.

Hawthorn Bancshares Inc is a financial holding company that, along with its subsidiary bank, provides commercial banking for small and mid-sized businesses, including equipment, operating, commercial real estate and SBA loans, and personal banking services such as real estate mortgage lending, installment and consumer loans, certificates of deposit, checking, savings and money market accounts. The company also provides trust services including estate planning, investment and asset management services, brokerage and cash management services. Its primary source of revenue is net interest income derived from lending and deposit taking activities, with much of its business in commercial, commercial real estate development and residential mortgage lending.

About SLGL Sol-Gel Technologies Ltd.

Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted.

Share on Social Networks: